Clin Exp Emerg Med. 2020 Jun;7(2):87-94. doi: 10.15441/ceem.19.050. Epub 2020 Jun 30.
Effect of complement C1-esterase inhibitor on brain edema and inflammation after mild traumatic brain injury in an animal model.
Clinical and experimental emergency medicine
Eric Weiss, Teena Dhir, Abigail Collett, Michal Reola, Mark Kaplan, Corrado Minimo, Laurel Omert, Pak Leung
Affiliations
Affiliations
- Department of Surgery, Einstein Healthcare Network, Philadelphia, PA, USA.
- Philadelphia College of Osteopathic Medicine, Philadelphia, PA, USA.
- Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, USA.
PMID: 32635699
PMCID: PMC7348678 DOI: 10.15441/ceem.19.050
Abstract
OBJECTIVE: Traumatic brain injury (TBI) is characterized by damage to the blood-brain barrier, inflammation, and edema formation. In this pilot study, we aimed to investigate the effects of a complement inhibitor, C1-esterase inhibitor (C1 INH), on brain edema and inflammation in a rat model of mild TBI.
METHODS: Thirty-six male Sprague Dawley rats were randomly assigned to control, TBI, or TBI plus C1 INH groups. TBI and TBI plus C1 INH rats received an injection of saline or 25 IU/kg C1 INH, respectively, with TBI using a weight drop model. Control rats received saline only. Rats were subsequently euthanized and their brain tissue harvested for analysis. The primary outcome was the extent of edema as assessed by the brain's water content. Secondary outcomes included enzyme-linked immunosorbent assays to determine levels of pro-inflammatory mediators.
RESULTS: Tumor necrosis factor-α levels were significantly greater in TBI rats than control rats, indicating that inflammation was generated by the weight drop impact. Brain water content following TBI was significantly different between TBI rats treated with C1-INH (78.7%±0.12), untreated TBI rats (79.3%±0.12), and control rats (78.6%±0.15, P=0.001). There was a significant decrease in C3a and interleukin 2 levels among C1 INH-treated rats compared with untreated TBI rats, but no change in levels of tumor necrosis factor-α and S100β.
CONCLUSION: C1-INH inhibited the complement pathway, suggesting that C1-INH may have a therapeutic benefit in TBI. Further studies are needed to investigate the effect of C1-INH on clinical outcomes.
Keywords: Brain injuries, traumatic; Complement system proteins; Cytokines; Edema; Inflammation
References
- PLoS One. 2013 Aug 26;8(8):e72059 - PubMed
- Transl Stroke Res. 2012 Jun;3(2):263-5 - PubMed
- Shock. 2007 Jul;28(1):29-34 - PubMed
- J Neuroimmunol. 1997 Mar;73(1-2):63-9 - PubMed
- J Neuroinflammation. 2016 Oct 11;13(1):264 - PubMed
- Handb Clin Neurol. 2016;138:207-23 - PubMed
- J Vis Exp. 2014 Dec 08;(94): - PubMed
- J Neurotrauma. 2001 Dec;18(12):1295-311 - PubMed
- Shock. 2012 Jul;38(1):82-91 - PubMed
- Front Cell Neurosci. 2014 Sep 09;8:269 - PubMed
- Clin J Am Soc Nephrol. 2015 Sep 4;10(9):1636-50 - PubMed
- J Immunol. 2014 Mar 1;192(5):2339-48 - PubMed
- Methods Mol Biol. 2016;1462:193-209 - PubMed
- Crit Care Med. 2009 Feb;37(2):659-65 - PubMed
- J Neurotrauma. 2013 Jun 1;30(11):920-37 - PubMed
- Shock. 2016 Sep;46(3 Suppl 1):177-88 - PubMed
- Nat Rev Neurol. 2010 Jul;6(7):393-403 - PubMed
- Brain Res Brain Res Rev. 1998 Aug;27(3):243-56 - PubMed
- Protein Sci. 1994 Aug;3(8):1169-77 - PubMed
- Trends Pharmacol Sci. 2015 Jul;36(7):471-80 - PubMed
- Acta Neurochir Suppl. 2008;102:381-4 - PubMed
- Neurosurg Clin N Am. 2016 Oct;27(4):473-88 - PubMed
- J Neuroinflammation. 2018 Jan 22;15(1):24 - PubMed
- J Trauma. 1993 Feb;34(2):216-22 - PubMed
- Neurology. 2001 Jun 26;56(12):1746-8 - PubMed
- Acta Neurochir (Wien). 2011 Jan;153(1):90-100 - PubMed
- J Neurotrauma. 2001 Aug;18(8):773-81 - PubMed
- Thromb Haemost. 2010 Nov;104(5):886-93 - PubMed
- MMWR Surveill Summ. 2017 Mar 17;66(9):1-16 - PubMed
Publication Types
Grant support